Mesenchymal stem cell therapy for intractable neonatal disorders

Mesenchymal stem cell therapy for intractable neonatal disorders

Mesenchymal stem cell (MSC) transplantation has emerged as a new promising therapeutic strategy for the treatment of intractable and devastating neonatal disorders with complex multifactorial etiologies, including bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and hypoxic-ische...

Full description

Saved in:
Bibliographic Details
Main Authors: So Yoon Ahn, Won Soon Park, Se In Sung, Yun Sil Chang
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Pediatrics and Neonatology
Subjects:
stem cells
stem cell transplantation
infant, newborn
clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957220301984
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items